| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 154, Issue 7 3500-3505, Copyright © 1995 by American Association of Immunologists
ARTICLES |
IM Adcock, SJ Lane, CR Brown, MJ Peters, TH Lee and PJ Barnes
Department of Thoracic Medicine, National Heart and Lung Institute, London, UK.
Although glucocorticosteroids are a very effective treatment for asthma and other chronic inflammatory diseases, a small proportion of patients are resistant to their therapeutic effects. The molecular mechanism for this steroid resistance is unclear. Steroid resistance cannot be explained by pharmacokinetic mechanisms, by a defect in the binding of steroids to glucocorticoid receptors, nor by defective nuclear translocation of this receptor, thereby suggesting that the molecular abnormality lies distal to nuclear translocation. We examined the ability of nuclear translocated glucocorticoid receptors to bind to their DNA binding sites (GRE) using electrophoretic mobility shift assays in PBMC from patients with steroid-sensitive and steroid- resistant asthma. The binding of the glucocorticoid receptor to DNA in these patients was also studied using Scatchard analysis. Dexamethasone induced a significant rapid and sustained twofold increase in GRE binding in PBMCs from steroid-sensitive asthmatic patients and nonasthmatic individuals, but this was markedly reduced in steroid- resistant asthmatic patients. Scatchard analysis of glucocorticoid receptor-GRE binding showed no change in binding affinity but did show a reduced number of receptors available for DNA binding in the steroid- resistant patients. These results suggest that the ability of the glucocorticoid receptor to bind to GRE is impaired in steroid-resistant patients because of a reduced number of receptors available for binding to DNA.
This article has been cited by other articles:
|
|
 |
|
  J. Ouyang, T. Jiang, M. Tan, Y. Cui, and X. Li Abnormal Expression and Distribution of Heat Shock Protein 90: Potential Etiologic Immunoendocrine Mechanism of Glucocorticoid Resistance in Idiopathic Nephrotic Syndrome Clin. Vaccine Immunol., April 1, 2006; 13(4): 496 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Tjandra, T Le, and M G Swain Glucocorticoid receptors are downregulated in hepatic T lymphocytes in rats with experimental cholangitis Gut, September 1, 2003; 52(9): 1363 - 1370. [Abstract] [Full Text]
|
|
|
|
 |
|
 G.U. Meduri, P. Carratu, and A.X. Freire Evidence of biological efficacy for prolonged glucocorticoid treatment in patients with unresolving ARDS Eur. Respir. J., August 1, 2003; 22(42_suppl): 57s - 64s. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. U. Meduri, E. A. Tolley, G. P. Chrousos, and F. Stentz Prolonged Methylprednisolone Treatment Suppresses Systemic Inflammation in Patients with Unresolving Acute Respiratory Distress Syndrome . Evidence for Inadequate Endogenous Glucocorticoid Secretion and Inflammation-induced Immune Cell Resistance to Glucocorticoids Am. J. Respir. Crit. Care Med., April 1, 2002; 165(7): 983 - 991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-K. Bae, M.-H. Bae, M.-Y. Ahn, M. J. Son, Y. M. Lee, M.-K. Bae, O.-H. Lee, B. C. Park, and K.-W. Kim Egr-1 Mediates Transcriptional Activation of IGF-II Gene in Response to Hypoxia Cancer Res., December 1, 1999; 59(23): 5989 - 5994. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. I. McKay and J. A. Cidlowski Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-{kappa}B and Steroid Receptor-Signaling Pathways Endocr. Rev., August 1, 1999; 20(4): 435 - 459. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. A. HAMID, S. E. WENZEL, P. J. HAUK, A. TSICOPOULOS, B. WALLAERT, J.-J. LAFITTE, G. P. CHROUSOS, S. J. SZEFLER, and D. Y. M. LEUNG Increased Glucocorticoid Receptor beta in Airway Cells of Glucocorticoid-insensitive Asthma Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1600 - 1604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. VACHIER, G. CHIAPPARA, A. M. VIGNOLA, R. GAGLIARDO, E. ALTIERI, B. TEROUANNE, P. VIC, J. BOUSQUET, P. GODARD, and P. CHANEZ Glucocorticoid Receptors in Bronchial Epithelial Cells in Asthma Am. J. Respir. Crit. Care Med., September 1, 1998; 158(3): 963 - 970. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Dashtaki, A. R. Whorton, T. M. Murphy, P. Chitano, W. Reed, and T. P. Kennedy Dehydroepiandrosterone and Analogs Inhibit DNA Binding of AP-1 and Airway Smooth Muscle Proliferation J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 876 - 883. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. BARNES, S. PEDERSEN, and W. W. BUSSE Efficacy and Safety of Inhaled Corticosteroids . New Developments Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): S1 - 53. [Full Text] [PDF]
|
|
|
|
 |
|
 D. Y.M. Leung, Q. Hamid, A. Vottero, S. J. Szefler, W. Surs, E. Minshall, G. P. Chrousos, and D. J. Klemm Association of Glucocorticoid Insensitivity with Increased Expression of Glucocorticoid Receptor beta J. Exp. Med., November 3, 1997; 186(9): 1567 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Oakley, J. C. Webster, M. Sar, C. R. Parker Jr., and J. A. Cidlowski Expression and Subcellular Distribution of the {beta}-Isoform of the Human Glucocorticoid Receptor Endocrinology, November 1, 1997; 138(11): 5028 - 5038. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
